Olga Golubnitschaja

Sigmund Freud Str. 25
Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 129 publications

Evidence-based recommendations for advancing the chronic pelvic pain syndrome management by the paradigm change from reactive symptom suppression to proactive 3PM-guided patient-centered care.

Evidence-based recommendations for advancing the chronic pelvic pain syndrome management by the paradigm change from reactive symptom suppression to proactive 3PM-guided patient-centered care.

Journal: The EPMA journal

Published: August 11, 2026

The specificity trap in routine tumor biomarker interpretation: Advancing the 3PM-based clinical decision framework to benefits of patients.

The specificity trap in routine tumor biomarker interpretation: Advancing the 3PM-based clinical decision framework to benefits of patients.

Journal: The EPMA journal

Published: July 29, 2026

Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity.

Adjuvant therapies by anthocyanins potentially mitigating drug resistance and metastatic disease risks in stratified breast cancers: the 3PM-conceptual innovation targeted to NF-kappaB/EMT plasticity.

Journal: The EPMA journal

Published: June 02, 2026

Thermoregulation and associated disorders: 3PM-guided holistic approach bridging innovative and traditional Chinese medicine.

Thermoregulation and associated disorders: 3PM-guided holistic approach bridging innovative and traditional Chinese medicine.

Journal: The EPMA journal

Published: February 26, 2026

From sympathetic overdrive phenotype to malignant transformation: 3PM-guided protection against health-to-disease transition and disease progression improving individual outcomes in primary and secondary care.

From sympathetic overdrive phenotype to malignant transformation: 3PM-guided protection against health-to-disease transition and disease progression improving individual outcomes in primary and secondary care.

Journal: The EPMA journal

Published: February 23, 2026

Innovative mitochondria-based holistic 3PM approach to female health status: Facts and outlook.

Innovative mitochondria-based holistic 3PM approach to female health status: Facts and outlook.

Journal: The EPMA journal

Published: December 19, 2025

Multimodal AI-based modeling of glaucoma progression: a 3PM-guided approach integrating structural, functional, and vascular patterns.

Multimodal AI-based modeling of glaucoma progression: a 3PM-guided approach integrating structural, functional, and vascular patterns.

Journal: The EPMA journal

Published: October 05, 2025

Bilberry (Vaccinium myrtillus L.) Peel-Enriched Pomace as Natural Anticancer Agents: Preclinical Evidence from Breast Carcinoma Models Supporting Preventive and Personalized Treatment Strategies.

Bilberry (Vaccinium myrtillus L.) Peel-Enriched Pomace as Natural Anticancer Agents: Preclinical Evidence from Breast Carcinoma Models Supporting Preventive and Personalized Treatment Strategies.

Journal: The Journal of nutrition

Published: September 03, 2025

How to use an extensive Flammer syndrome phenotyping for a holistic protection against health-to-disease transition - facts and practical recommendations.

How to use an extensive Flammer syndrome phenotyping for a holistic protection against health-to-disease transition - facts and practical recommendations.

Journal: The EPMA journal

Published: July 26, 2025

Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation.

Flavonoid-modulated JAK-STAT signaling mitigates malignant transformation and drug resistance in breast tumors: A clinically relevant 3PM-guided innovation.

Journal: Journal of advanced research

Published: July 17, 2025

Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients.

Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients.

Journal: The EPMA journal

Published: February 24, 2025

Mitochondrial medicine: "from bench to bedside" 3PM-guided concept.

Mitochondrial medicine: "from bench to bedside" 3PM-guided concept.

Journal: The EPMA journal

Published: February 24, 2025

Showing 1-12 of 129

Last Updated: 09/26/2026